Washington D.C. [USA], August 15 (ANI): A team of researchers collaborated to gain a better understanding of the interaction among ovarian cancer tumours, blood vessels and platelets. They found that tumours break the blood vessel barriers so that they can communicate with the blood cells, s
Ohio [USA], August 5 (ANI): A new study suggests the risk of coronary artery disease (CAD) could be identified earlier by looking at reproductive risk factors.
New York [USA], July 30 (ANI): Women receiving standard treatment in New York City for ovarian, uterine, and cervical cancers are not at increased risk of being hospitalised for -- or dying from-- COVID-19 due to their cancer, a new study shows.
Gurugram (Haryana) [India], July 12 (ANI): Paras Hospital in Gurugram became first in the city to perform Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC) on a patient who had run out of options after her ovarian cancer recurred for the third time.
Cleveland [Ohio], June 24 (ANI): While women with premature ovarian insufficiency (POI) become estrogen deficient at an early age, which makes them more vulnerable to the loss of bone mineral density, a new study suggests that use of continuous combined oral contraceptives may be especially
Boston [USA], June 21 (ANI): Patients with high-grade serious ovarian cancer (HGSOC) who were treated with the drug, berzosertib, and chemotherapy lived substantially longer before their disease began to worsen than did those treated with chemotherapy alone, according to a recent study.
Montreal [Canada], June 20 (ANI): Better management of patients with severe combined immunodeficiency (SCID) can be enabled with the new test developed by the researchers of CHU Sainte-Justine in Montreal.
Boston [USA], June 16 (ANI): In its first randomised clinical trial, investigators report a drug that targets a protein needed by cancer cells to maintain their dogged growth and division has shown considerable promise in combination with chemotherapy in patients with a common form of ovaria
Washington D.C. [USA], April 27 (ANI): In a first-time disclosure of IPN60090, a small-molecule inhibitor of the metabolic enzyme glutaminase (GLS1), researchers reported the preclinical discovery and early-stage clinical development of this novel drug. IPN60090, now under investigation in a
Brisbane [Australia], April 3 (ANI): An international study involving researchers from QIMR Berghofer Medical Research Institute has found women who breastfeed their babies may lower their risk of developing ovarian cancer by almost 25 percent.
Washington D.C. [USA], Feb 17 (ANI): In a breakthrough step to improve the diagnosis of ovarian cancer, researchers have a simple blood test that measures the body's own immune response. The new study found that testing for a specific immune biomarker allows clinicians to identify whether gr